ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
52 hedge funds and large institutions have $41.2M invested in Oncternal Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
25% more call options, than puts
Call options by funds: $320K | Put options by funds: $256K
Holders
52
Holding in Top 10
–
Calls
$320K
Puts
$256K
Top Buyers
| 1 | +$6.88M | |
| 2 | +$5.05M | |
| 3 | +$3.57M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.85M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.78M |
Top Sellers
| 1 | -$2.24M | |
| 2 | -$2.04M | |
| 3 | -$1.85M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$331K |
| 5 |
Renaissance Technologies
New York
|
-$241K |